ReWalk Robotics, the innovative medical device company, is set to unveil its third-quarter figures on November 14, amidst growing anticipation within the industry. Experts on Wall Street predict that the company will report a loss per share of $0.110, a small increase from the previous year’s loss of $0.090 during the same quarter. The company’s stock price will be closely monitored on Markets Insider in real-time, reflecting the keen interest of investors.
Despite the projected losses, there is a newfound optimism surrounding ReWalk Robotics. The Wall Street analysts are bullish on the company’s sales trajectory, forecasting a remarkable 380.90% increase compared to the previous year’s quarter, with sales predicted to reach $0.9 million. This notable growth can be attributed to the increasing demand and acceptance of ReWalk’s groundbreaking robotic exoskeleton technology, offering mobility solutions for individuals with spinal cord injuries.
Looking ahead to the fiscal year, analysts anticipate a loss per share of $0.350, signifying a slight improvement from the previous year’s loss of $0.310. The sales estimates for the year also demonstrate a robust outlook, with an average of $14.1 million expected, soaring past the $5.5 million recorded in the previous fiscal period. These positive projections reflect the market’s confidence in the company’s ability to capitalize on the potential in the assistive robotics market.
As ReWalk Robotics continues to make headlines, pioneering the field of medical robotics, the company’s innovative approach to enhancing the lives of individuals with mobility impairments remains at the forefront of its strategy. With ongoing advancements and diligent research, ReWalk Robotics is poised to lead the way in redefining the possibilities for individuals with spinal cord injuries.
Frequently Asked Questions (FAQ)
Q: What is ReWalk Robotics?
ReWalk Robotics is a medical device company that specializes in developing robotic exoskeletons to assist individuals with spinal cord injuries, enabling them to regain mobility.
Q: When will ReWalk Robotics release its Q3 figures?
ReWalk Robotics is expected to release its third-quarter figures on November 14.
Q: What are the anticipated losses per share for ReWalk Robotics in Q3?
Analysts predict that ReWalk Robotics will report a loss per share of $0.110 in the third quarter, slightly higher than the previous year’s loss of $0.090 in the same period.
Q: Is ReWalk Robotics experiencing sales growth?
Yes, Wall Street analysts are optimistic about ReWalk Robotics’ sales growth. The company is projected to experience a substantial increase of 380.90% in sales compared to the previous year’s quarter, with sales predicted to reach $0.9 million.
Q: What are the analysts’ expectations for ReWalk Robotics’ fiscal year?
Analysts expect a loss per share of $0.350 for the fiscal year, indicating a slight improvement from the previous year’s loss of $0.310. Sales estimates average $14.1 million, significantly higher than the $5.5 million recorded in the previous fiscal period.